^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | Opdivo (nivolumab) (PD1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Endometrial cancer: Systemic Therapy for Endometrial Carcinoma...Recurrent, Metastatic or High-risk Disease...Biomarker-directed systemic therapy for second-line treatment...Nivolumab